Member Info for itsallamess

"The Company currently envisages that a further Traumakine trial is likely to be funded through third party funding"Japanese partners to fund their side, new partner to fund euro and american side are on the books.Remember when the CEO said that there was investors waiting in the side lines who said if anything changes give us a call... well YODA has proved everything has changed... expect news here soon on Traumakine next stepsPlus clevegen paitent treatment update and partner news

2.2% or 3.5p higher

Good day of consolidation, SP holding up well which shows good RNS last week wasnt a spike.

This sort of small daily rise is what has taken us up 122% or 88p rise over the past 4 weeks

Onwards and upwards!

For ghe believers:

Who buys 3 shares... triple RNS on itscway.

1. Clevegen update
2. Partmer paying for Traumakine trial
3. New partner for clevegen

Dan, I'm slightly confused!

But would prefer to be correct as that means our free float is tiny :)

"The percentage of AIM securities not in public hands (as defined by the AIM rules) 22.85%"
I'm not sure who theses guys are?

"Certain early Pre-IPO investors* hold a significant amount of Company's shares, with a total of 57.18%"
These are all the over 3% holders listed on the website

These 2 groups equals 80.03% of shares in issue (call them sticky hands)

Which means the free float of shares that are potentially traded are just 19.97%

Can someone confirm this is correct?

Just one point i noticed on the new website
"Attis is focused on delivering sustainable long term returns to its shareholders..."

How long is "long term" cause ive been sitting here with a paper loss for quite some time, even averaging down but long term is sounding like never!

Cyno
Jap trial was conducted and paid for by our jap partner, so maybe when our CEO said the re trail will be paid for by a partner he was refering in part to them...

The specialty pharma company Maruishi Pharmaceutical Co., Ltd. based in Osaka, Japan has been licensed Traumakine® in return for up to €5 million in development payments. The Traumakine® Phase II clinical trial was completed in Japan with positive top-line results, and Maruishi has now begun the pivotal Phase III clinical trial.

Maruishi will cover all the development costs in Japan in respect of Traumakine®. Faron is to receive a share of Maruishi´s net profits of Traumakine® through milestones, royalties and other payments. To date, Faron has received €2.3 million in milestone payments pursuant to its agreement with Maruishi and is due to receive up to an additional €2.7 million subject to certain key development milestones being met

But while i havent been able to post, just to say what a great week last week was.

We droped a couple of pence monday through wednesday and then.. boom.. great RNS and it was game on again

Well done everyone holding and who managed to get in

Tip for you all;

Dont say anything negitive about the CEO on the PREM BB... they arevery sensitive over there and you likly will be reported and banned!

Tip for you all;

Dont say anything negitive about the CEO on the PREM BB... they arevery sensitive over there and you likly will be reported and banned!

So i was suspended last week

"Your account has been suspended from posting in Share Chat until 08:00 on Mon, 17th Jun 2019
Reason for suspension: Potentially libellous or defamatory content. Your next suspension for posting similar will result in a permanent suspension being added"

One more transgression and thats me banned!

All you can hope for is another webner interview thing where he answers questions life from typingvthem to him.. at leaast you can all have a good laugh

They know whT they are doing, ran out of shares... lower the SP, leave it hovering, scare some into thinking that it could either go down loads or not move up to cause investors to sell out!

Still very much in a news window,

Said this before but the trial being tested on clevegen can only do a tumour Xray once a month... initial results were amazing then they were upingthe dosage... that was when the last interview was made one month ago

I'm expecting a update from this anyday now!

Steady rises = good strong share

https://www.tallymoney.com/our-story

You'd think RH would get a new pair of shoes for his photo on the about us page on the website!

If you did then know this

Sold out = locked out!

A few more buys than sells and the sp has risen

Hang on to your golden tickets guys cause this is gonna rocket!

Check out tbe video below and go and search for zens and my socks cause they have well and truly been blown off!

Thinking about investing here

Check out the latest interview from 3 weeks ago and tell me this doesnt blow your socks off!
https://youtu.be/mpnlP-ETN-o

Gonna be a cracking week.

Consolodation last couple of day... more buys than sells, tiny free float, plus loads of news

Everyone knows the future to killing cancer in immunotherapy and FARN are on the cutting edge of the science behind it... already they have had great results for a paitent when 6 other treatments did nothing

Doctors declare 'golden age of cancer treatment' https://mol.im/a/7119089 via http://dailym.ai/android

Look at the one month chart... you will see 4 tiny drops on thecway up. Main point we are rising overall

Bottom line... again more bpughtvthan sold... less shares off the open market, free float shrinking even more